Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

β 2-Adrenergic agonist salbutamol augments hypertrophy in MHCIIa fibers and sprint mean power output but not muscle force during 11 weeks of resistance training in young men.

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Physiological responses of human skeletal muscle to acute blood flow restricted exercise assessed by multimodal MRI

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Reply to Dutheil et al

    Research output: Contribution to journalComment/debateResearchpeer-review

  3. Regional collagen turnover and composition of the human patellar tendon

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Menstrual cycle phase does not affect whole body peak fat oxidation rate during a graded exercise test

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Potential Severe Asthma Hidden in UK Primary Care

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The Prevalence of Subtypes of Type 2 Inflammation in an Unselected Population of Patients with Severe Asthma

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Severe outcomes of COVID-19 among patients with COPD and asthma

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

In this study, we examined the effect of β 2-agonist salbutamol at oral doses during a period of resistance training on sprint performance, quadriceps contractile function, skeletal muscle hypertrophy, fiber type composition, maximal activity of enzymes of importance for anaerobic energy turnover, and sarcoplasmic reticulum Ca 2+ handling in young men. Twenty-six men (23 ± 2 yr; means ± SD) were randomized to daily intake of oral salbutamol (16 mg/day; RES+SAL) or placebo (RES) during 11 wk of full-body resistance training 3 times/wk. Mean power output during 10-s maximal cycling increased more ( P = 0.027) in RES+SAL (+12%) than in RES (+7%), whereas peak power output increased similarly (RES+SAL: +8%; RES: +7%; P = 0.400). Quadriceps dynamic peak torque and maximal voluntary isometric torque increased by 13 and 14% ( P ≤ 0.001) in RES+SAL and 13 and 13% ( P ≤ 0.001) in RES, respectively. Myosin heavy-chain (MHC) isoform distribution transitioned from MHCI and MHCIIx toward MHCIIa in RES+SAL ( P = 0.002), but not in RES ( P = 0.323). MHCIIa cross-sectional-area increased more ( P = 0.040) in RES+SAL (+35%) than RES (+21%). Sarcoplasmic reticulum Ca 2+ release rate increased in both groups (RES+SAL: +9%, P = 0.048; RES: +13%, P = 0.008), whereas Ca 2+-uptake rate increased only in RES (+12%, P = 0.022) but was not different from the nonsignificant change in RES+SAL (+2%, P = 0.484). Maximal activity of lactate dehydrogenase increased only in RES+SAL (+13%, P = 0.008). Muscle content of the dihydropyridine receptor, ryanodine receptor 1, and sarcoplasmic reticulum Ca 2+-ATPase isoform 1 and 2 did not change with the intervention in either group ( P ≥ 0.100). These observations indicate that the enhancement of sprint mean power output induced by salbutamol is at least partly attributed to greater hypertrophy of MHCIIa fibers and transition toward the MHCIIa isoform. NEW & NOTEWORTHY Here, we show that daily oral treatment with selective β 2-agonist salbutamol induces muscle fiber isoform transition from myosin-heavy-chain (MHC)-I toward MHCIIa and augments hypertrophy of MHCIIa fibers during a period of resistance training. Compared with placebo, salbutamol enhanced sprint mean power output, whereas peak power output and measures of muscle strength increased similarly during the resistance training period despite augmented hypertrophy with salbutamol. Thus, salbutamol is a muscle anabolic drug that can enhance sprint ability adaptations to resistance training.

Original languageEnglish
JournalJournal of Applied Physiology
Volume130
Issue number3
Pages (from-to)617-626
Number of pages10
ISSN0161-7567
DOIs
Publication statusPublished - 1 Mar 2021

ID: 61983839